👉 The updated fluid refers to a more advanced and refined version of traditional blood substitutes, designed to mimic the oxygen-carrying and supportive functions of natural red blood cells more effectively. This new fluid incorporates novel components such as engineered hemoglobin variants, nanotechnology, and advanced biocompatible materials to enhance oxygen delivery, reduce the risk of immune reactions, and improve overall patient outcomes. It represents a significant advancement in addressing blood shortages, treating anemia, and providing therapeutic support in critical care settings, while also aiming to reduce the logistical and financial burdens associated with blood transfusions.
